Christoph Kahlert

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

M. Koch, P. Schirmacher, J. Weitz, 2009, British Journal of Cancer.

Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer

M. Koch, N. Halama, C. Pilarsky, 2014, Oncotarget.

Evaluation of the inflammatory markers CCL8, CXCL5, and LIF in patients with anastomotic leakage after colorectal cancer surgery

N. Halama, S. Schuler, A. Ulrich, 2020, International Journal of Colorectal Disease.

Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer

Sara Al-Madhi, M. Venerito, Yue Zhao, 2023, British journal of cancer.

Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.

D. Campa, F. Canzian, W. Greenhalf, 2024, International journal of cancer.